Edesa Biotech (EDSA) FCF Margin (2013 - 2020)
Edesa Biotech (EDSA) posted FCF Margin of 329662.0% for Q3 2020, down 31005.44% sequentially from 1059.82% in Q1 2020.
Edesa Biotech (EDSA) FCF Margin (2013 - 2020) Analysis & Trends
Edesa Biotech has reported FCF Margin for 8 years, with the latest figure at 329662.0% in Q3 2020.
- Quarterly FCF Margin changed N/A year-over-year to 329662.0% in Q3 2020, while the trailing twelve-month figure through Jun 2021 was 2993106.2% (down 299250980.0% YoY) and the FY2020 annual result came in at 1518.0%, down 33663.0% from the prior year.
- FCF Margin declined to 329662.0% in Q3 2020 per EDSA's latest filing, from 1059.82% in the prior quarter.
- Over five years, FCF Margin peaked at 695.23% in Q3 2017 and troughed at 704325.6% in Q2 2019.
- A 5-year average of 80953.8% and a median of 1059.82% in 2020 frame the typical range for FCF Margin.
- The widest YoY moves for FCF Margin: up 80002 bps in 2017, down 473421 bps in 2017.
- Over 5 years, FCF Margin stood at 1021.78% in 2016, then sank by 463 bps to 5755.99% in 2017, then jumped by 58 bps to 2434.79% in 2018, then soared by 70 bps to 732.57% in 2019, then tumbled by 44901 bps to 329662.0% in 2020.
- According to Business Quant data, FCF Margin over the past three periods registered 329662.0%, 1059.82%, and 732.57% for Q3 2020, Q1 2020, and Q4 2019 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 30.39% |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 13.35% |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -388.28% |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 25.68% |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 22.62% |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -22.35% |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 70.82% |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 41.07% |
| 10 | Edesa Biotech | 43.15 Mn | 43.15 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | -329,662.00% |
| Mar 31, 2020 | -1,059.82% |
| Dec 31, 2019 | -732.57% |
| Jun 30, 2019 | -704,325.60% |
| Mar 31, 2018 | -2,434.79% |
| Dec 31, 2017 | -5,755.99% |
| Sep 30, 2017 | 695.23% |
| Jun 30, 2017 | -4,942.66% |
| Mar 31, 2017 | -2,092.41% |
| Dec 31, 2016 | -1,021.78% |
| Sep 30, 2016 | -104.79% |
| Jun 30, 2016 | -606.35% |
| Mar 31, 2016 | -355.83% |
| Dec 31, 2015 | -295.85% |
| Sep 30, 2015 | 463.16% |
| Jun 30, 2015 | -672.68% |
| Mar 31, 2015 | -921.82% |
| Dec 31, 2014 | -622.77% |
| Dec 31, 2013 | -8,057.30% |